CENK

WIPO WIPO 2021

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark CENK was filed as Word mark on 01/04/2021 at the World Intellectual Property Organization.

Trademark Details Last update: June 9, 2023

Trademark form Word mark
File reference 1577926
Countries Australia Canada European Community United Kingdom Japan South Korea Singapore
Base trademark US No. 90036788, July 6, 2020
Application date January 4, 2021
Expiration date January 4, 2031

Trademark owner

3530 John Hopkins Court
San Diego CA 92121
US

Trademark representatives

525 William Penn Place, 28th Floor PITTSBURGH PA 15202 US

goods and services

01 Cells for scientific, laboratory, medical, clinical, therapeutic, and diagnostic research; cell-derived preparations, namely, natural killer cell-derived preparations, for scientific, laboratory, medical, clinical, therapeutic, and diagnostic research; kits comprised of cells, reagents and related instructions, for clinical, medicinal, and therapeutic research purposes; kits comprised of cell-derived preparations, namely, natural killer cell-derived preparations, reagents and related instructions, for clinical, medicinal, and therapeutic research purposes
05 Cells for clinical, medical, veterinary, and therapeutic purposes; cell-derived preparations, namely, natural killer cell-derived preparations, for clinical, medical, veterinary, and therapeutic purposes; therapeutic products derived from cells, namely, natural killer cells, for clinical, medical, veterinary, and therapeutic purposes; therapeutic products derived from cell-derived preparations, namely, natural killer cell-derived preparations, for clinical, medical, veterinary, and therapeutic purposes; kits comprised of cells, reagents and related instructions, for clinical, medicinal, veterinary, and therapeutic purposes; kits comprised of cell-derived preparations, namely, natural killer cell-derived preparations, reagents and related instructions, for clinical, medicinal, veterinary, and therapeutic purposes
42 Research in the field of cancer; product development in the fields of science, medicine, pharmaceuticals, veterinary medicine, therapeutics and research related thereto
44 Providing information relating to clinical, medicinal, and therapeutic properties of cells and cell-derived preparations

Trademark history

Date Document number Area Entry
May 17, 2023 2023/23 Gaz US RAW: Partial Ceasing Effect
August 30, 2022 2022/35 Gaz KR RAW: Rule 18ter(2)(ii) GP following a provisional refusal
June 22, 2022 2022/25 Gaz CA Rejection
May 19, 2022 2022/21 Gaz JP RAW: Rule 18ter(2)(ii) GP following a provisional refusal
January 7, 2022 2022/2 Gaz JP Rejection
January 4, 2022 2022/1 Gaz KR Rejection
November 26, 2021 2021/49 Gaz SG RAW: Rule 18ter(2)(ii) GP following a provisional refusal
July 21, 2021 2021/30 Gaz EM Rejection
July 8, 2021 2021/29 Gaz GB Rejection
July 6, 2021 2021/30 Gaz AU RAW: Rule 18ter(2)(ii) GP following a provisional refusal
June 15, 2021 2021/25 Gaz SG Rejection
March 30, 2021 2021/14 Gaz AU Rejection
January 4, 2021 2021/6 Gaz US Registration

ID: 141577926